NCT04524858View on ClinicalTrials.gov

Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)

PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

October 23, 2020

Primary Completion Date

February 25, 2021

Study Completion Date

February 25, 2021

Conditions
Cryopyrin-Associated Periodic Syndrome
Interventions
DRUG

ATI-450

Oral, small molecule MK2 inhibitor

Trial Locations (2)

92123

Aclaris Investigational Site, San Diego

94116

Aclaris Investigational Site, San Francisco

Sponsors
All Listed Sponsors
lead

Aclaris Therapeutics, Inc.

INDUSTRY

NCT04524858 - Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS) | Biotech Hunter | Biotech Hunter